Effect of EP4 agonist (ONO-4819CD) for patients with mild to moderate ulcerative colitis refractory to 5-aminosalicylates: A randomized phase II, placebo-controlled trial
Hiroshi Nakase(Sapporo Medical University), Shuh Narumiya(Kyoto University), Yoshiyasu Esaki, Satoshi Teramukai(Kyoto University Hospital), Toshinori Murayama(Northwestern University), Nobuhide Oshitani, Kimiko Nonomura(Kyoto University), Toshiyuki Matsuoka(Kyoto University), Tsutomu Chiba(Kyoto University), Yoshihide Fujiyama(Shiga University of Medical Science), Toru Oga(Kawasaki Medical School)
Cited by 54
Related Papers
The Phagocytic Function of Macrophage-Enforcing Innate Immunity and Tissue Homeostasis
|International Journal of Molecular Sciences|2017|916
Intramyocardial Transplantation of Autologous CD34 <sup>+</sup> Stem Cells for Intractable Angina
|Circulation|2007|557
Injection of Cultured Cells with a ROCK Inhibitor for Bullous Keratopathy
|New England Journal of Medicine|2018|551
Alternative splicing of C-terminal tail of prostaglandin E receptor subtype EP3 determines G-protein specificity
|Nature|1993|550
Ligand binding specificities of the eight types and subtypes of the mouse prostanoid receptors expressed in Chinese hamster ovary cells
|British Journal of Pharmacology|1997|512